Cargando…

Tonsillar cytokine expression between patients with tonsillar hypertrophy and recurrent tonsillitis

BACKGROUND: Tonsils provide an innovative in vivo model for investigating immune response to infections and allergens. However, data are scarce on the differences in tonsillar virus infections and immune responses between patients with tonsillar hypertrophy or recurrent tonsillitis. We investigated...

Descripción completa

Detalles Bibliográficos
Autores principales: Mikola, Emilia, Elenius, Varpu, Saarinen, Maria, Palomares, Oscar, Waris, Matti, Turunen, Riitta, Puhakka, Tuomo, Ivaska, Lotta, Rückert, Beate, Aab, Alar, Vahlberg, Tero, Vuorinen, Tytti, Allander, Tobias, Camargo, Carlos A., Akdis, Mübeccel, Akdis, Cezmi A., Jartti, Tuomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5963068/
https://www.ncbi.nlm.nih.gov/pubmed/29942488
http://dx.doi.org/10.1186/s13601-018-0205-z
_version_ 1783324982779052032
author Mikola, Emilia
Elenius, Varpu
Saarinen, Maria
Palomares, Oscar
Waris, Matti
Turunen, Riitta
Puhakka, Tuomo
Ivaska, Lotta
Rückert, Beate
Aab, Alar
Vahlberg, Tero
Vuorinen, Tytti
Allander, Tobias
Camargo, Carlos A.
Akdis, Mübeccel
Akdis, Cezmi A.
Jartti, Tuomas
author_facet Mikola, Emilia
Elenius, Varpu
Saarinen, Maria
Palomares, Oscar
Waris, Matti
Turunen, Riitta
Puhakka, Tuomo
Ivaska, Lotta
Rückert, Beate
Aab, Alar
Vahlberg, Tero
Vuorinen, Tytti
Allander, Tobias
Camargo, Carlos A.
Akdis, Mübeccel
Akdis, Cezmi A.
Jartti, Tuomas
author_sort Mikola, Emilia
collection PubMed
description BACKGROUND: Tonsils provide an innovative in vivo model for investigating immune response to infections and allergens. However, data are scarce on the differences in tonsillar virus infections and immune responses between patients with tonsillar hypertrophy or recurrent tonsillitis. We investigated the differences in virus detection and T cell and interferon gene expression in patients undergoing tonsillectomy due to tonsillar hypertrophy or recurrent tonsillitis. METHODS: Tonsils of 89 surgical patients with tonsillar hypertrophy (n = 47) or recurrent tonsillitis (n = 42) were analysed. Patients were carefully characterized clinically. Standard questionnaire was used to asses preceding and allergy symptoms. Respiratory viruses were analysed in tonsils and nasopharynx by PCR. Quantitative real-time PCR was used to analyse intratonsillar gene expressions of IFN-α, IFN-β, IFN-γ, IL-10, IL-13, IL-17, IL-28, IL-29, IL-37, TGF-β, FOXP3, GATA3, RORC2 and Tbet. RESULTS: Median age of the subjects was 15 years (range 2–60). Patients with tonsillar hypertrophy were younger, smoked less often, had less pollen allergy and had more adenovirus, bocavirus-1, coronavirus and rhinovirus in nasopharynx (all P < 0.05). Only bocavirus-1 was more often detected in hypertrophic tonsils (P < 0.05). In age-adjusted analysis, tonsillar hypertrophy was associated with higher mRNA expressions of IL-37 (P < 0.05). CONCLUSIONS: Intratonsillar T cell and interferon gene expressions appeared to be relatively stable for both tonsillar hypertrophy and recurrent tonsillitis. Of the studied cytokines, only newly discovered anti-inflammatory cytokine IL-37, was independently associated with tonsillar hypertrophy showing slightly stronger anti-inflammatory response in these patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13601-018-0205-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5963068
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-59630682018-06-25 Tonsillar cytokine expression between patients with tonsillar hypertrophy and recurrent tonsillitis Mikola, Emilia Elenius, Varpu Saarinen, Maria Palomares, Oscar Waris, Matti Turunen, Riitta Puhakka, Tuomo Ivaska, Lotta Rückert, Beate Aab, Alar Vahlberg, Tero Vuorinen, Tytti Allander, Tobias Camargo, Carlos A. Akdis, Mübeccel Akdis, Cezmi A. Jartti, Tuomas Clin Transl Allergy Research BACKGROUND: Tonsils provide an innovative in vivo model for investigating immune response to infections and allergens. However, data are scarce on the differences in tonsillar virus infections and immune responses between patients with tonsillar hypertrophy or recurrent tonsillitis. We investigated the differences in virus detection and T cell and interferon gene expression in patients undergoing tonsillectomy due to tonsillar hypertrophy or recurrent tonsillitis. METHODS: Tonsils of 89 surgical patients with tonsillar hypertrophy (n = 47) or recurrent tonsillitis (n = 42) were analysed. Patients were carefully characterized clinically. Standard questionnaire was used to asses preceding and allergy symptoms. Respiratory viruses were analysed in tonsils and nasopharynx by PCR. Quantitative real-time PCR was used to analyse intratonsillar gene expressions of IFN-α, IFN-β, IFN-γ, IL-10, IL-13, IL-17, IL-28, IL-29, IL-37, TGF-β, FOXP3, GATA3, RORC2 and Tbet. RESULTS: Median age of the subjects was 15 years (range 2–60). Patients with tonsillar hypertrophy were younger, smoked less often, had less pollen allergy and had more adenovirus, bocavirus-1, coronavirus and rhinovirus in nasopharynx (all P < 0.05). Only bocavirus-1 was more often detected in hypertrophic tonsils (P < 0.05). In age-adjusted analysis, tonsillar hypertrophy was associated with higher mRNA expressions of IL-37 (P < 0.05). CONCLUSIONS: Intratonsillar T cell and interferon gene expressions appeared to be relatively stable for both tonsillar hypertrophy and recurrent tonsillitis. Of the studied cytokines, only newly discovered anti-inflammatory cytokine IL-37, was independently associated with tonsillar hypertrophy showing slightly stronger anti-inflammatory response in these patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13601-018-0205-z) contains supplementary material, which is available to authorized users. BioMed Central 2018-05-22 /pmc/articles/PMC5963068/ /pubmed/29942488 http://dx.doi.org/10.1186/s13601-018-0205-z Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Mikola, Emilia
Elenius, Varpu
Saarinen, Maria
Palomares, Oscar
Waris, Matti
Turunen, Riitta
Puhakka, Tuomo
Ivaska, Lotta
Rückert, Beate
Aab, Alar
Vahlberg, Tero
Vuorinen, Tytti
Allander, Tobias
Camargo, Carlos A.
Akdis, Mübeccel
Akdis, Cezmi A.
Jartti, Tuomas
Tonsillar cytokine expression between patients with tonsillar hypertrophy and recurrent tonsillitis
title Tonsillar cytokine expression between patients with tonsillar hypertrophy and recurrent tonsillitis
title_full Tonsillar cytokine expression between patients with tonsillar hypertrophy and recurrent tonsillitis
title_fullStr Tonsillar cytokine expression between patients with tonsillar hypertrophy and recurrent tonsillitis
title_full_unstemmed Tonsillar cytokine expression between patients with tonsillar hypertrophy and recurrent tonsillitis
title_short Tonsillar cytokine expression between patients with tonsillar hypertrophy and recurrent tonsillitis
title_sort tonsillar cytokine expression between patients with tonsillar hypertrophy and recurrent tonsillitis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5963068/
https://www.ncbi.nlm.nih.gov/pubmed/29942488
http://dx.doi.org/10.1186/s13601-018-0205-z
work_keys_str_mv AT mikolaemilia tonsillarcytokineexpressionbetweenpatientswithtonsillarhypertrophyandrecurrenttonsillitis
AT eleniusvarpu tonsillarcytokineexpressionbetweenpatientswithtonsillarhypertrophyandrecurrenttonsillitis
AT saarinenmaria tonsillarcytokineexpressionbetweenpatientswithtonsillarhypertrophyandrecurrenttonsillitis
AT palomaresoscar tonsillarcytokineexpressionbetweenpatientswithtonsillarhypertrophyandrecurrenttonsillitis
AT warismatti tonsillarcytokineexpressionbetweenpatientswithtonsillarhypertrophyandrecurrenttonsillitis
AT turunenriitta tonsillarcytokineexpressionbetweenpatientswithtonsillarhypertrophyandrecurrenttonsillitis
AT puhakkatuomo tonsillarcytokineexpressionbetweenpatientswithtonsillarhypertrophyandrecurrenttonsillitis
AT ivaskalotta tonsillarcytokineexpressionbetweenpatientswithtonsillarhypertrophyandrecurrenttonsillitis
AT ruckertbeate tonsillarcytokineexpressionbetweenpatientswithtonsillarhypertrophyandrecurrenttonsillitis
AT aabalar tonsillarcytokineexpressionbetweenpatientswithtonsillarhypertrophyandrecurrenttonsillitis
AT vahlbergtero tonsillarcytokineexpressionbetweenpatientswithtonsillarhypertrophyandrecurrenttonsillitis
AT vuorinentytti tonsillarcytokineexpressionbetweenpatientswithtonsillarhypertrophyandrecurrenttonsillitis
AT allandertobias tonsillarcytokineexpressionbetweenpatientswithtonsillarhypertrophyandrecurrenttonsillitis
AT camargocarlosa tonsillarcytokineexpressionbetweenpatientswithtonsillarhypertrophyandrecurrenttonsillitis
AT akdismubeccel tonsillarcytokineexpressionbetweenpatientswithtonsillarhypertrophyandrecurrenttonsillitis
AT akdiscezmia tonsillarcytokineexpressionbetweenpatientswithtonsillarhypertrophyandrecurrenttonsillitis
AT jarttituomas tonsillarcytokineexpressionbetweenpatientswithtonsillarhypertrophyandrecurrenttonsillitis